ArticleEcancermedicalscience2022

Biweekly cetuximab in combination with capecitabine and oxaliplatin (XELOX) or irinotecan (XELIRI) in the first-line and second-line treatment of patients with RAS wild-type metastatic colorectal cancer.

Jamal Zekri et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.